Krzysztof Krzemieniecki

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients

A.T. van Oosterom, H.T. Mouridsen, Ole S. Nielsen et al. · European Journal of Cancer · 2002 · 164 citations

Medicine, Oncology, Pharmacology +13

Hippo pathway - brief overview of its relevance in cancer.

Aneta L. Zygulska, Krzysztof Krzemieniecki, Piotr Pierzchalski · PubMed · 2017 · 83 citations

Medicine, Cancer Biology, Oncology +17

Assessment of knowledge about cervical cancer and its prevention among female students aged 17–26 years

Wojciech Kamzol, Katarzyna Jaglarz, Krzysztof A. Tomaszewski et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2012 · 57 citations

Medicine, Health Education, Preventive Medicine +16

High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience

Iwona Filipczak-Bryniarska, Roger M. Krzyżewski, Jakub Kucharz et al. · Medical Oncology · 2017 · 53 citations · Full text

Medicine, Neurology, Pharmacotherapy +10